Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients
Status:
Not yet recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled trial assessing Losartan in reducing radiation
induced fibrosis in breast cancer patients undergoing standard of care radiation therapy
after surgery.